ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Heart/lung transplantation"

  • 2017 American Transplant Congress

    Routine Surveillance of Heart Transplant Recipients with Gene Expression Profiling: Lack of an Impact of Race on Outcomes.

    J. Teuteberg,1 M. Shullo,1 D. Rinde-Hoffman,2 M. Wigger,3 Y. Wang,4 T. Wolf,4 P. Arnold,4 J. Sninsky,4 P. Berman.2

    1University of Pittsburgh Medical Center, Pittsburgh, PA; 2Tampa General Hospital, Tampa, FL; 3Vanderbilt Heart and Vascular Institution, Nashville, TN; 4CareDx, Brisbane, CA

    Purpose: Patients of African descent have been reported to have less favorable outcomes after heart transplantation than patients of European descent. However, the impact of…
  • 2017 American Transplant Congress

    In the Modern Era, Cytomegalovirus Does Not Appear to Increase Intimal Thickening After Heart Transplantation.

    D. Leong, B. Azarbal, J. Patel, M. Kittleson, L. Czer, T. Aintablian, D. Chang, D. Geft, J. Kobashigawa.

    Cedars-Sinai Heart Institute, Los Angeles

    Background: Cytomegalovirus (CMV) has been associated with the subsequent development of cardiac allograft vasculopathy (CAV) after heart transplantation. In the more recent era, CMV has…
  • 2017 American Transplant Congress

    Does the Model for End Stage Liver Disease (MELD) Score Predict Outcome in Total Artificial Heart Patients?

    M. Rafiei, J. Moriguchi, M. Kittleson, J. Patel, T. Aintablian, E. Passano, R. Sharoff, J. Kwan, E. Kransdorf, D. Chang, L. Czer, J. Kobashigawa, F. Arabia.

    Cedars-Sinai Heart Institute, Los Angeles

    The total artificial heart (TAH) is being used for biventricular failure in patients with severe heart disease. Patients(pts) who have received a left ventricular assist…
  • 2017 American Transplant Congress

    Simultaneous Heart and Kidney Transplant vs Heart Transplant: Single Center Review of Candidate Selection and List Management.

    N. Fonseka,1 H. Mangrolia,1 S. Karhadkar,2 S. Rao,2 L. Punnoose.1

    1Temple Heart and Vascular Institute, Lewis Katz School of Medicine at Temple University, Philadelphia, PA; 2Temple Kidney Transplant Program, Lewis Katz School of Medicine at Temple University, Philadelphia, PA

    Background: Increasing numbers of patients with advanced heart and kidney failure undergo simultaneous heart kidney transplant (SHK). Selection criteria in patients with non-dialysis dependent kidney…
  • 2017 American Transplant Congress

    Severe Tricuspid Regurgitation After Heart Transplantation: Does It Require Surgical Repair?

    J. Patel, M. Kittleson, L. Czer, T. Aintablian, R. Sharoff, R. Levine, A. Velleca, D. Ramzy, F. Esmailian, J. Kobashigawa.

    Cedars-Sinai Heart Institute, Los Angeles

    Background: Tricuspid regurgitation (TR) after heart transplantation is common. Causes for TR may be due to volume overload, flail tricuspid leaflet from endomyocardial biopsy, pulmonary…
  • 2017 American Transplant Congress

    Preventing Alloimmune Rejection in Heart Transplantation by Tolerogenic Dendritic Cells Induced by GDF15 Through Up-Regulation of IDO and Inhibition of the NFκB Signalling Pathway.

    Y. Zhang,1,3 G. Zhang,1 L. Moszczynski,1 D. Zhao,1,3 P. Abulizi,1 D. Quan,2 T. Mele,2 K. Liu,3 X. Zheng.1,2

    1Pathology, University of Western Ontario, London, ON, Canada; 2Surgery, University of Western Ontario, London, ON, Canada; 3Cardiovascular Surgery, Jilin University, Cahngchun, China

    Rationale: Growth differentiation factor 15 (GDF15) can inhibit DC maturation, yet whether it can generate tolerogenic dendritic cells (Tol-DCs) to induce immune tolerance in heart…
  • 2017 American Transplant Congress

    Ethylene Carbodiimide Fixed Donor Splenocytes Combined with α-1 Antitrypsin Induce Indefinite Donor Specific Protection to Mice Cardiac Allografts.

    G. Chen, X. Lai, L. Qiu, Y. Zhao, S. Yu, J. Zhang, L. Chen.

    Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

    Peritransplant infusion of ethylene carbodiimide fixed donor splenocytes(ECDI-SPs) induces protection of islet and cardiac allografts. However, pro-inflammatory cytokine production during the peritransplantation period may negate…
  • 2017 American Transplant Congress

    Heat Shock Protein 90 Inhibitor, 17DMAG Suppresses Acute Allograft Rejection and Prolongs Allograft Survival in Solid Organ Transplantation.

    T. Maehana, T. Tanaka, N. Masumori.

    Urology, Sapporo Medical University School of Medicine, Sapporo, Japan

    Purpose: Heat shock protein 90 (HSP90) is a ubiquitously expressed molecular chaperone that is associated with the correct activation of client proteins. Important roles of…
  • 2017 American Transplant Congress

    B Cell-Derived Cytokines Rather Than T/B Cognate Interactions Mediate CD8 T Cell Reconstitution Following Lymphoablation.

    D. Zwick, K. Ayasoufi, R. Fan, V. Gorbacheva, K. Keslar, R. Fairchild, A. Valujskikh.

    Immunology, Cleveland Clinic, Cleveland, OH

    Antibody-mediated lymphoablation is a commonly used induction therapy in sensitized transplant recipients. Using murine anti-thymocyte globulin (mATG) in a model of BALB/c (H-2d) to B6…
  • 2017 American Transplant Congress

    The Ultimate Calculated Panel Reactive Antibody Value Predicts Mortality After Heart Transplantation.

    E. Kransdorf,1 M. Kittleson,1 J. Patel,1 M. Pando,2 L. Czer,1 J. Kobashigawa.1

    1Cedars-Sinai Heart Institute, Los Angeles; 2Mayo Clinic Arizona, Phoenix

    Background: Sensitized heart transplant (HT) candidates are known to be at higher risk for adverse events after transplantation, including a positive crossmatch, rejection, and death.…
  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 23
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences